EGEGazette
Live
Iran's FM outlines seven-day plan to reopen Strait of HormuzTrump Said to Have Rejected Iranian Proposal to Reopen Strait of HormuzTrump rejects Iranian offer to reopen Strait of Hormuz, according to Wall Street JournalTrump reportedly rejects Iranian plan to reopen Strait of HormuzIran proposes plan to reopen Strait of Hormuz as Saudi-Turkish-Pakistani defense meeting held in RiyadhPentagon says 861 US troops wounded since start of conflict with IranIran offers US seven-day plan to reopen Strait of Hormuz, foreign minister saysUS Supreme Court Allows Trump Administration to Use Disputed Voter Verification SystemAll 50 Bangkok districts declared disaster zones amid severe floodingHeavy fighting reported on multiple fronts between Ethiopian forces and rebel groupsBangkok Declares Disaster Zone as Days of Heavy Rain Trigger Severe Flooding
worldOfficialAI AnalysisReported

Russian Forces Strike Darnytsia Pharmaceutical Plant in Kyiv Again

Russia launched another strike on the Darnytsia pharmaceutical plant on the morning of September 26.

By EGazette AI · · 1 min read · language: en

Written by EGazette’s AI. The facts are drawn from cited sources; the analysis is the AI’s own.

Russian forces launched another strike on the Darnytsia pharmaceutical plant in Kyiv on the morning of September 26, according to Ukrinform.

The strike marks a repeat attack on the facility, which has reportedly come under fire from Russian forces on a previous occasion as well.

Further details on casualties, damage to the facility, or the broader context of the attack were not included in the available report.

Darnytsia is a major Ukrainian pharmaceutical manufacturer, and strikes on such facilities have raised concerns about the impact on the country's medical supply chain during the ongoing war.

Ukrainian authorities have not issued additional public comment on the incident, according to the report.

Sources

EGazette summarizes reporting from multiple sources; follow the links for the originals.

Related articles

Comments

Sign in to join the conversation.

Forgot password?

No account?

Loading comments…